10x Genomics (TXG) Debt Ratio (2018 - 2019)

10x Genomics (TXG) posted Debt Ratio of 0.05 for Q4 2019, down 5.37% sequentially from 0.05 in Q3 2019, and down 79.45% YoY from 0.24 in Q4 2018.

10x Genomics (TXG) Debt Ratio (2018 - 2019) Analysis & Trends

10x Genomics has reported Debt Ratio for 2 years, with the latest figure at 0.05 in Q4 2019.

Quarterly Debt Ratio fell 79.45% year-over-year to 0.05 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 0.05 (down 79.45% YoY) and the FY2019 annual result came in at 0.05, down 79.45% from the prior year.
Debt Ratio declined to 0.05 in Q4 2019 per TXG's latest filing, from 0.05 in the prior quarter.
Over five years, Debt Ratio peaked at 0.24 in Q4 2018 and troughed at 0.05 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	0.37
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	0.29
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	0.25
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Privia Health	2.78 Bn	2.42 Bn	-	-

Download Data